MB-106

· Mustang Bio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB-106, covering 2024-07-22 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL [Phase 1, Phase 2]

See pricing